Version 2 2024-06-03, 07:25Version 2 2024-06-03, 07:25
Version 1 2014-11-04, 13:37Version 1 2014-11-04, 13:37
journal contribution
posted on 2024-06-03, 07:25authored byP Gran, AE Larsen, M Bonham, AL Dordevic, T Rupasinghe, C Silva, A Nahid, D Tull, Andrew SinclairAndrew Sinclair, CJ Mitchell, D Cameron-Smith
The mammalian target of rapamycin (mTOR) pathway is the primary regulator of muscle protein synthesis. Metabolic syndrome (MetS) is characterized by central obesity and insulin resistance; little is known about how MetS affects the sensitivity of the mTOR pathway to feeding.